Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Nature Communications|August 21, 2023
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosisZihan Tang, Yanyan Xu, Yun Tan, et al.Nature|May 21, 2020
Viral and host factors related to the clinical outcome of COVID-19Xiaonan Zhang, Yun Tan, Yun Ling, et al.Signal Transduction and Targeted Therapy|May 19, 2026
Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodelingHuimin Li, Yabin Liu, Jiachen Cui, et al.Nature Communications|September 15, 2022
Pangenomic analysis of Chinese gastric cancerYingyan Yu, Zhen Zhang, Xiaorui Dong, et al.Cell Discovery|June 9, 2021
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19Yun Tan, Wei Zhang, Zhaoqin Zhu, et al.Cell Research|July 4, 2015
Mutation of kri1l causes definitive hematopoiesis failure via PERK-dependent excessive autophagy inductionXiao-E Jia, Ke Ma, Tao Xu, et al.Signal Transduction and Targeted Therapy|November 18, 2025
Multidimensional tumor-blood profiling uncovers systemic lymphocyte-monocyte imbalance in pituitary neuroendocrine tumorsYuting Dai, Shaojian Lin, Junchen Wu, et al.Nature Medicine|January 29, 2024
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinomaLingxi Jiang, Jiejie Qin, Yuting Dai, et al.Proceedings of the National Academy of Sciences of the United States of America|April 8, 2020
Effectiveness of convalescent plasma therapy in severe COVID-19 patientsKai Duan, Bende Liu, Cesheng Li, et al.Innovation (Cambridge (Mass.))|May 14, 2023
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III studyHuijuan Zhong, Shu Cheng, Xi Zhang, et al.Pageof 10